Company research

Pelthos Therapeutics Inc. (PTHS) stock fundamentals

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagio

As of 2026-10-08

Exchange
XASE
Sector
Healthcare
Industry
Biotechnology

Company overview

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

Daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing PTHS with another company.

Daily close (USD)$20.5
Market capitalization (USD)$78,483,614.5
Price / earnings (TTM)Not reported
Price / bookNot reported

Read PTHS's valuation metrics

  1. Company size

    Pelthos Therapeutics Inc.'s recorded market capitalization is $78,483,614.5. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

  3. Price relative to book equity

    Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.

Research Pelthos Therapeutics Inc. with Aurora

Use the snapshot above to ask a specific question about PTHS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow PTHS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.